Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Arm, Open Label, Phase II Trial of WP1066 and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

NCT05879250 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT05879250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05879250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Arm, Open Label, Phase II Trial of WP1066 and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Recruiting
Start date
May 22, 2024
Completion date
December 27, 2028
Enrollment
39 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, idh-wildtype, mgmt-unmethylated glioblastoma